Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19
SYDNEY--(BUSINESS WIRE)--#Covid19--Australian clinical-stage drug development company Noxopharm (ASX:NOX) has reported preclinical data that further supports…